February 25, 2011 – A diagnostic test used to help treat patients with high cholesterol received CE mark approval in Europe. The KIF6 genotyping assay, from Abbott, detects a genetic marker that may be used in conjunction with clinical evaluation and patient assessment for the identification of individuals at risk for coronary heart disease (CHD).

February 25, 2011 – A larger transcatheter aortic heart valve has received the CE mark. The 29 mm version of the Sapien XT valve, from Edwards Lifesciences, promises to expand the number of patients who can be treated.

February 24, 2011 – The U.S. Food and Drug Administration (FDA) will no longer require review or approval of technology that helps increase interoperability between devices and information systems. The move is being made to simplify the flow of information between medical devices and electronic medical record systems.

February 24, 2011 – Upsher-Smith Laboratories, is voluntarily recalling one lot (lot #284081) of Jantoven Warfarin Sodium, USP, 3 mg tablets, an anticoagulant with an expiration date of September 2012, NDC # 0832-1214-00.

February 24, 2011 – A percutaneous microwave tissue ablation (pMTA) system will be unveiled at the European Congress of Radiology (ECR) in Vienna, Austria, March 4-7. The Accu2i pMTA system, from Microsulis Medical is cleared for use in Europe, the United States and Canada.

Alongside the Accu2i, Microsulis will feature case studies from key centers using the system.

February 22, 2011 – More than 29 IHE Integration profiles were successfully certified at the IHE North American Connectathon in Chicago. The announcement from Medweb came at the 2011 Healthcare Information and Management Systems Society (HIMMS).

February 21, 2011 – A cardiac computed tomography (CT) report engine was approved by the U.S. Food and Drug Administration (FDA) to save physicians' time, to present instant feedback on their interpretation and to vastly reduce time to diagnosis.

The C saves physicians time, presents instant feedback on their interpretation and vastly reduces time to diagnosis.

February 21, 2011 – Scottsdale Healthcare Shea Medical Center in Arizona is the first hospital in the southwestern United States to implant a magnetic resonance imaging (MRI)-safe pacemaker. This represents a major technological breakthrough for patients who need MRI diagnostic scans, which can damage older style pacemakers or cause serious health complications.

February 21, 2011 – Two drug-eluting coronary stent systems have been launched in India. Boston Scientific’s Promus Element everolimus-eluting stent system and Taxus Element paclitaxel-eluting coronary stent system incorporate the same novel platinum chromium (PtCr) alloy.

They also have the same stent design and advanced catheter delivery system.

February 21, 2011 – The first patient has been enrolled the DESSOLVE II study to support CE mark for a coronary stent that uses a bioresorbable drug polymer. The MiStent drug-eluting coronary stent system (MiStent DES), by Micell Technologies.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now